Evidence map›Paper›PMID 32317643›Full record

ArticleNature communications2020

Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis.

Tatsuya Tsukui, Kai-Hui Sun, Joseph B Wetter, John R Wilson-Kanamori, Lisa A Hazelwood, Neil C Henderson, Taylor S Adams, Jonas C Schupp, Sergio D Poli, Ivan O Rosas and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 501 papers.

0numbers the graph read from it
0cells of the map it votes in
501citing papers in PubMed
43.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

501 citing papers in PubMed, 714 citations in OpenAlex.

  1. Trial
  2. Review
  3. Potential role of CTHRC1 in renal fibrosis.Molecular biology reports · 2026
    Review
  4. Targeting the CD4Molecular biomedicine · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. An NFATC4 phospho-switch links matrix stiffness to fibroblast fate.The Journal of clinical investigation · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

441 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Tatsuya TsukuiLung Biology Center, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-3100-6934
Kai-Hui SunLung Biology Center, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Joseph B WetterAbbvie Inc, North Chicago, IL, USA.
John R Wilson-KanamoriCentre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
Lisa A HazelwoodAbbvie Inc, North Chicago, IL, USA.
Neil C HendersonCentre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0002-2273-4094
Taylor S AdamsSection of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Jonas C SchuppSection of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-7714-8076
Sergio D PoliBrigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Ivan O RosasBrigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Naftali KaminskiSection of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0001-5917-4601
Michael A MatthayDepartments of Medicine and Anesthesia, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, USA.
Paul J WoltersDivision of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Dean SheppardLung Biology Center, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. Dean.Sheppard@ucsf.edu.ORCID http://orcid.org/0000-0002-6277-2036
University of California, San Francisco · USYale University · USAbbVie (United States) · USBrigham and Women's Hospital · USCentre for Inflammation Research · GB

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Respiratory Computational Discovery CoreP01HL114501 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CHOI, MARY E · 2013 to 2025
$24.9M
Targeting Epithelial Cells To Treat Pulmonary FibrosisP01HL108794 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PAPA, FEROZ R · 2012 to 2016
$12.6M
Genomic Analysis of Tissue and Cellular Heterogeneity in IPFR01HL127349 · NHLBI · YALE UNIVERSITY · PI BENOS, PANAGIOTIS V, KAMINSKI, NAFTALI · 2015 to 2025
$5.9M
Treatment of pulmonary fibrosis with inhibitors of integrin alphavbeta1.UH3HL123423 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEGRADO, WILLIAM, SHEPPARD, DEAN · 2016 to 2018
$4.5M
Alveolar DevMAPU01HL122626 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AMBALAVANAN, NAMASIVAYAM, HAGOOD, JAMES S. · 2014 to 2018
$3.7M
Fibroblast heterogeneity in pulmonary fibrosisR01HL142568 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SHEPPARD, DEAN · 2020 to 2023
$2.9M
Treatment of pulmonary fibrosis with inhibitors of integrin alphavbeta1.UH2HL123423 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEGRADO, WILLIAM, SHEPPARD, DEAN · 2014 to 2015
$2.2M
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS P01 HL108794NHLBI NIH HHS P01 HL114501NHLBI NIH HHS R01 HL127349NHLBI NIH HHS R01 HL142568NHLBI NIH HHS U01 HL122626NHLBI NIH HHS UH2 HL123423NHLBI NIH HHS UH3 HL123423Wellcome TrustWellcome Trust 103749
6 · The paper itself

Abstract

Collagen-producing cells maintain the complex architecture of the lung and drive pathologic scarring in pulmonary fibrosis. Here we perform single-cell RNA-sequencing to identify all collagen-producing cells in normal and fibrotic lungs. We characterize multiple collagen-producing subpopulations with distinct anatomical localizations in different compartments of murine lungs. One subpopulation, characterized by expression of Cthrc1 (collagen triple helix repeat containing 1), emerges in fibrotic lungs and expresses the highest levels of collagens. Single-cell RNA-sequencing of human lungs, including those from idiopathic pulmonary fibrosis and scleroderma patients, demonstrate similar heterogeneity and CTHRC1-expressing fibroblasts present uniquely in fibrotic lungs. Immunostaining and in situ hybridization show that these cells are concentrated within fibroblastic foci. We purify collagen-producing subpopulations and find disease-relevant phenotypes of Cthrc1-expressing fibroblasts in in vitro and adoptive transfer experiments. Our atlas of collagen-producing cells provides a roadmap for studying the roles of these unique populations in homeostasis and pathologic fibrosis.

Indexed as

AnimalsCell SeparationCollagenExtracellular Matrix ProteinsFemaleFibroblastsFlow CytometryGreen Fluorescent ProteinsHigh-Throughput Nucleotide SequencingHumansIdiopathic Pulmonary FibrosisLungMaleMiceMice, Inbred C57BLPhenotypeCollagenCTHRC1 protein, humanExtracellular Matrix ProteinsGreen Fluorescent Proteins

Identifiers

PMID32317643
PMCPMC7174390
OpenAlexW3016965350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.